Ryuta Nakae1, Shoji Yokobori2, Yasuhiro Takayama2, Takahiro Kanaya2, Yu Fujiki3, Yutaka Igarashi2, Go Suzuki3, Yasutaka Naoe3, Akira Fuse2, Hiroyuki Yokota2. 1. Department of Emergency and Critical Care Medicine, Nippon Medical School, 1-1-5, Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan. nakae@nms.ac.jp. 2. Department of Emergency and Critical Care Medicine, Nippon Medical School, 1-1-5, Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan. 3. Emergency and Critical Care Center, Kawaguchi Municipal Medical Center, Saitama, Japan.
Abstract
BACKGROUND: The association between traumatic brain injury (TBI) and coagulopathy is well established. While coagulopathy prophylaxis in TBI involves replenishing coagulation factors with fresh frozen plasma (FFP), its effectiveness is controversial. We investigated the relationship between plasma fibrinogen concentration 3 h after initiating FFP transfusion and outcomes and evaluated the correlation with D-dimer levels at admission. METHODS: We retrospectively examined data from 380 patients with severe isolated TBI with blood samples collected a maximum of 1 h following injury. Plasma fibrinogen and D-dimer concentrations were obtained at admission, and plasma fibrinogen concentration was again assessed 3-4 h following injury. The patients were divided into two groups based on whether or not they received FFP transfusion. Patients were also divided into subgroups according their fibrinogen level: ≥ 150 mg/dL (high-fibrinogen subgroup) or < 150 mg/dL (low-fibrinogen subgroup) 3 h after injury. Demographic, clinical, radiological and laboratory data were compared between these subgroups. RESULTS: Glasgow Outcome Scale (GOS) scores at discharge and 3 months after injury were significantly lower in the FFP transfusion group than in the FFP non-transfusion group. Among patients who received FFP, GOS scores at discharge and 3 months after injury were significantly higher in the high-fibrinogen subgroup than in the low-fibrinogen subgroup. Elevated admission D-dimer predicted subsequent fibrinogen decrease. CONCLUSIONS: In FFP transfusion, fibrinogen level ≥ 150 mg/dL 3 h after injury was associated with better outcomes in TBI patients. Assessing the admission D-dimer and tracking the fibrinogen are crucial for optimal coagulopathy prophylaxis in TBI patients.
BACKGROUND: The association between traumatic brain injury (TBI) and coagulopathy is well established. While coagulopathy prophylaxis in TBI involves replenishing coagulation factors with fresh frozen plasma (FFP), its effectiveness is controversial. We investigated the relationship between plasma fibrinogen concentration 3 h after initiating FFP transfusion and outcomes and evaluated the correlation with D-dimer levels at admission. METHODS: We retrospectively examined data from 380 patients with severe isolated TBI with blood samples collected a maximum of 1 h following injury. Plasma fibrinogen and D-dimer concentrations were obtained at admission, and plasma fibrinogen concentration was again assessed 3-4 h following injury. The patients were divided into two groups based on whether or not they received FFP transfusion. Patients were also divided into subgroups according their fibrinogen level: ≥ 150 mg/dL (high-fibrinogen subgroup) or < 150 mg/dL (low-fibrinogen subgroup) 3 h after injury. Demographic, clinical, radiological and laboratory data were compared between these subgroups. RESULTS: Glasgow Outcome Scale (GOS) scores at discharge and 3 months after injury were significantly lower in the FFP transfusion group than in the FFP non-transfusion group. Among patients who received FFP, GOS scores at discharge and 3 months after injury were significantly higher in the high-fibrinogen subgroup than in the low-fibrinogen subgroup. Elevated admission D-dimer predicted subsequent fibrinogen decrease. CONCLUSIONS: In FFP transfusion, fibrinogen level ≥ 150 mg/dL 3 h after injury was associated with better outcomes in TBIpatients. Assessing the admission D-dimer and tracking the fibrinogen are crucial for optimal coagulopathy prophylaxis in TBIpatients.
Authors: Ronald Chang; Lindley E Folkerson; Duncan Sloan; Jeffrey S Tomasek; Ryan S Kitagawa; H Alex Choi; Charles E Wade; John B Holcomb Journal: Surgery Date: 2016-10-21 Impact factor: 3.982
Authors: Dietmar Fries; Petra Innerhofer; Peter Perger; Manfred Gütl; Sabine Heil; Nikolaus Hofmann; Werner Kneifel; Ludwig Neuner; Thomas Pernerstorfer; Georg Pfanner; Herbert Schöchl; Bernhard Ziegler; Camillo Kölblinger; Sibylle Kozek-Langenecker Journal: Anasthesiol Intensivmed Notfallmed Schmerzther Date: 2010-09-13 Impact factor: 0.698
Authors: Catherine O Anglin; Jeffrey S Spence; Matthew A Warner; Christopher Paliotta; Caryn Harper; Carol Moore; Ravi Sarode; Christopher Madden; Ramon Diaz-Arrastia Journal: J Neurosurg Date: 2012-12-21 Impact factor: 5.115
Authors: Christopher B Allard; Sandro Scarpelini; Shawn G Rhind; Andrew J Baker; Pang N Shek; Homer Tien; Michael Fernando; Lorraine Tremblay; Laurie J Morrison; Ruxandra Pinto; Sandro B Rizoli Journal: J Trauma Date: 2009-11
Authors: Sjoerd Greuters; Annelies van den Berg; Gaby Franschman; Victor A Viersen; Albertus Beishuizen; Saskia M Peerdeman; Christa Boer Journal: Crit Care Date: 2011-01-05 Impact factor: 9.097